European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

European Union - English - EMA (European Medicines Agency)

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Canada - English - Health Canada

bayer inc consumer care - acetylsalicylic acid; calcium carbonate; magnesium oxide; magnesium carbonate - tablet - 325mg; 160mg; 63mg; 34mg - acetylsalicylic acid 325mg; calcium carbonate 160mg; magnesium oxide 63mg; magnesium carbonate 34mg - salicylates

European Union - English - EMA (European Medicines Agency)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - acute coronary syndromemyocardial infarction

Canada - English - Health Canada

bayer inc consumer care - acetylsalicylic acid; calcium carbonate; magnesium carbonate; magnesium oxide - tablet - 500mg; 246.2mg; 52.3mg; 96.9mg - acetylsalicylic acid 500mg; calcium carbonate 246.2mg; magnesium carbonate 52.3mg; magnesium oxide 96.9mg - salicylates

Malta - English - Medicines Authority

bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - citric acid, acetylsalicylic acid, sodium hydrogen, carbonate - effervescent tablet - acetylsalicylic acid 324 mg citric acid 965 mg sodium hydrogen carbonate 1744 mg - analgesics

Canada - English - Health Canada

bayer inc consumer care - acetylsalicylic acid; calcium carbonate; magnesium oxide; magnesium carbonate - tablet - 500mg; 246.22mg; 96.95mg; 52.32mg - acetylsalicylic acid 500mg; calcium carbonate 246.22mg; magnesium oxide 96.95mg; magnesium carbonate 52.32mg - salicylates

Canada - English - Health Canada

sterling winthrop inc. - acetylsalicylic acid; calcium carbonate; magnesium oxide; magnesium carbonate - tablet - 325mg; 160mg; 63mg; 34mg - acetylsalicylic acid 325mg; calcium carbonate 160mg; magnesium oxide 63mg; magnesium carbonate 34mg - salicylates

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Israel - English - Ministry of Health

bayer israel ltd - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.